Why the study?
Does erythrityl tetranitrate (oral, sublingual, chewable) improve diastolic amplitude response intensity compared to placebo in normal men?
Does erythrityl tetranitrate (oral, sublingual, chewable) improve diastolic amplitude response intensity compared to placebo in normal men?
All dosage forms of erythrityl tetranitrate are bioavailable, with the oral form demonstrating the longest duration of hemodynamic effect.
Answers are grounded in this paper and cite their sources.
Supports ETN use for acute hemodynamic effects; confirms bioavailability across routes with oral offering longest duration.
The bioavailability or oral, sublingual, and chewable tablets or erythrityl tetranitrate (ETN) was evaluated in 15 normal men. In a randomized, complete crossover investigation with nitroglycerin and placebo controls, drug-induced changes in the diastolic amplitude response intensity were measured with a digital plethysmogram. Values for area under the response intensity curve (AUC), maximum response intensity (Imax), and time lapse from dosing to peak response (tmax) were obtained by computer processing and converted to intensity values and AUC segments for specific time intervals. Sublingual nitroglycerin induced a response (p less than 0.05) from placebo within the first hour. Although somewhat slower in reaching peak intensity, all forms of ETN induced significant responses over placebo (p less than 0.05) for 2 hr, with oral (swallowed) ETN different 6 hr. Our results indicate that all the ETN dosage forms were bioavailable, with the longest duration of effect by the oral form.
No takes yet. Share an insight, caveat, or question.
Hannemann et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: